跳至主要内容
临床试验/EUCTR2016-001590-32-ES
EUCTR2016-001590-32-ES进行中(未招募)1 期

Comparison of two protocols of controlled ovarian stimulation with highly purified menotropin in low-responder patients according to Bologna criteria treated in Spanish public hospitals.

Manuel Macía Cortiñas0 个研究点目标入组 64 人开始时间: 2018年2月8日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • 1. Patients who initiate COS therapy with GnRH agonist and ICSI.
  • 2. Age <40 years with primary infertiliy including tubal factor.
  • 3. Patients with low ovarian reserve (must meet at least two of the three Bologna criteria: RFA <7 in both ovaries, AMH <0.5-1.1 ng/dL and low response to stimulation in a previous cycle, defined as recovery of <4 oocytes or canceled cycle).
  • 4. Normal or mild male factor (SMR=3 millions, normal morphology 4%).
  • 5. BMI <30 kg/m2.
  • 6. Presence of normal ovulatory cycles (every 26-35 days).
  • 7. Patients who sign informed consent.
  • 8. Presence of both ovaries.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 64
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. Endometriosis or uterine malformation
  • 2. PCOS according to Rotterdam criteria
  • 3. Presence of hydrosalping
  • 4. Intolerance or allergy to drugs
  • 5. Moderate or severe male factor

研究者

发起方
Manuel Macía Cortiñas

相似试验